array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Tekla Life Sciences Investors" ["slug"]=> string(38) "30be8-us-tekla-life-sciences-investors" ["logo"]=> NULL ["description"]=> string(523) "Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL." ["address_street"]=> string(17) "2 Liberty Sq FL 9" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2000-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(24) "https://www.teklacap.com" ["industry_codes"]=> array(1) { [0]=> string(39) "Management Investment Offices, Open-End" } ["employee_count"]=> int(7) ["article_count"]=> int(80) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(84) "Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P." ["snippet_en"]=> string(158) "Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in ..." ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-11-30/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3002266e-8d28-47bf-a243-7dc9f574377a" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-11-30" ["categories"]=> array(8) { [0]=> string(12) "Stock Market" [1]=> string(18) "General Investment" [2]=> string(11) "Acquisition" [3]=> string(20) "Corporate Governance" [4]=> string(31) "Financial Update/Profit Warning" [5]=> string(14) "Issuing Shares" [6]=> string(24) "Quarterly/Annual Figures" [7]=> string(16) "Share Repurchase" } } [1]=> array(7) { ["title_en"]=> string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn" ["snippet_en"]=> string(161) "BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to ..." ["url"]=> string(101) "https://www.fintechnews.org/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn/" ["image_url"]=> NULL ["source"]=> string(15) "fintechnews.org" ["publication_date"]=> string(10) "2023-10-29" ["categories"]=> array(5) { [0]=> string(20) "Business Development" [1]=> string(10) "Divestment" [2]=> string(11) "Acquisition" [3]=> string(25) "Business Model Resilience" [4]=> string(22) "Business Restructuring" } } [2]=> array(7) { ["title_en"]=> string(72) "Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC" ["snippet_en"]=> string(159) "RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent ..." ["url"]=> string(112) "https://www.defenseworld.net/2023/10/09/johnson-johnson-nysejnj-shares-bought-by-rnc-capital-management-llc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/541f0636-9fd8-491d-8e1a-8da06ab1b9dc" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-10-09" ["categories"]=> array(9) { [0]=> string(18) "Expansion & Growth" [1]=> string(12) "Stock Market" [2]=> string(18) "General Investment" [3]=> string(11) "Regulations" [4]=> string(11) "Acquisition" [5]=> string(31) "Financial Update/Profit Warning" [6]=> string(14) "Issuing Shares" [7]=> string(24) "Quarterly/Annual Figures" [8]=> string(16) "Share Repurchase" } } [3]=> array(7) { ["title_en"]=> string(47) "Tekla Life Sciences Investors Paid Distribution" ["snippet_en"]=> string(47) "Tekla Life Sciences Investors Paid Distribution" ["url"]=> string(53) "https://www.tmcnet.com/usubmit/2023/09/29/9890242.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1b793880-7aad-4194-850e-8657ae430324" ["source"]=> string(10) "tmcnet.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(1) { [0]=> string(23) "Supply Chain Management" } } [4]=> array(7) { ["title_en"]=> string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)" ["snippet_en"]=> string(157) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its ..." ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(10) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(18) "General Investment" [3]=> string(11) "Regulations" [4]=> string(11) "Acquisition" [5]=> string(31) "Financial Update/Profit Warning" [6]=> string(14) "Issuing Shares" [7]=> string(24) "Quarterly/Annual Figures" [8]=> string(19) "Investment Requests" [9]=> string(16) "Share Repurchase" } } [5]=> array(7) { ["title_en"]=> string(47) "Tekla Life Sciences Investors Paid Distribution" ["snippet_en"]=> string(155) "BOSTON, September 29, 2023--On September 29, 2023, Tekla Life Sciences Investors paid a distribution of $0.32 per share. It is currently estimated that ..." ["url"]=> string(80) "https://finance.yahoo.com/news/tekla-life-sciences-investors-paid-143500127.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3ca016b0-1e3d-460f-a082-899125631904" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(0) { } } [6]=> array(7) { ["title_en"]=> string(90) "Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ..." ["snippet_en"]=> string(157) "On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's ..." ["url"]=> string(85) "https://finance.yahoo.com/news/insider-buying-president-daniel-omstead-090129980.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c4a0c45d-f201-4981-be22-137183d32e53" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-09-21" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(16) "Share Repurchase" [2]=> string(11) "Acquisition" [3]=> string(14) "Issuing Shares" } } [7]=> array(7) { ["title_en"]=> string(110) "Tekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares Immediately" ["snippet_en"]=> string(39) "BOSTON--(BUSINESS WIRE)--Sep 13, 2023--" ["url"]=> string(196) "https://www.bakersfield.com/ap/news/tekla-funds-announce-adjournment-of-special-meetings-and-implore-shareholders-to-vote-their-shares-immediately/article_5eca924b-6c73-58fd-a9d5-9423d5752c8f.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f87bd777-283d-4f98-b9de-1bc02cb2206a" ["source"]=> string(15) "bakersfield.com" ["publication_date"]=> string(10) "2023-09-13" ["categories"]=> array(2) { [0]=> string(21) "Shareholders Feedback" [1]=> string(14) "Issuing Shares" } } [8]=> array(7) { ["title_en"]=> string(59) "Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend" ["snippet_en"]=> string(149) "Tekla Life Sciences Investors said on August 15, 2023 that its board of directors declared a regular quarterly dividend of $0.32 per share ($1.28 ..." ["url"]=> string(91) "https://www.nasdaq.com/articles/tekla-life-sciences-investors-hql-declares-$0.32-dividend-0" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-08-24" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(22) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(16) } [1]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(6) } [2]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(6) } [3]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [9]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } } } 30be8-us-tekla-life-sciences-investors

Tekla Life Sciences Investors

Location

Massachusetts

Founded

2000-01-26

Website

https://www.teklacap.com

Articles

80 Articles

Category

Management Investment Offices, Open-End

Description

Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL.

Articles

Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P.

2023-11-30 (marketbeat.com)

Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P.

Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in ...

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-10-29 (fintechnews.org)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to ...

Read more
Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC

2023-10-09 (defenseworld.net)

Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC

RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent ...

Read more
Tekla Life Sciences Investors Paid Distribution

2023-09-29 (tmcnet.com)

Tekla Life Sciences Investors Paid Distribution

Tekla Life Sciences Investors Paid Distribution

Read more
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)

2023-09-29 (marketbeat.com)

Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)

Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its ...

Read more
Tekla Life Sciences Investors Paid Distribution

2023-09-29 (yahoo.com)

Tekla Life Sciences Investors Paid Distribution

BOSTON, September 29, 2023--On September 29, 2023, Tekla Life Sciences Investors paid a distribution of $0.32 per share. It is currently estimated that ...

Read more
Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...

2023-09-21 (yahoo.com)

Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...

On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's ...

Read more
Tekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares Immediately

2023-09-13 (bakersfield.com)

Tekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares Immediately

BOSTON--(BUSINESS WIRE)--Sep 13, 2023--

Read more
Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend

2023-08-24 (nasdaq.com)

Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend

Tekla Life Sciences Investors said on August 15, 2023 that its board of directors declared a regular quarterly dividend of $0.32 per share ($1.28 ...

Read more

Newsletter subscription